Novel Iron(III)-Based Metal-Organic Gels with Superior Catalytic Performance toward Luminol Chemiluminescence.

Novel metal-organic gels (MOGs) consisting of iron (Fe3+) as the central ion and 1,10-phenanthroline-2,9-dicarboxylic acid (PDA) as the ligand were synthesized by a mild facile strategy. The Fe(III)-containing metal-organic xerogels (Fe-MOXs), obtained after removing the solvents in MOGs, were found to exhibit outstanding performance in the catalysis of luminol chemiluminescence (CL) for the first time even in the absence of extra oxidants such as hydrogen peroxide. The possible CL mechanism was discussed according to the electro/optical measurements, including electron paramagnetic resonance (EPR), UV-vis absorption, and CL spectra, as well as the effects of radical scavengers on Fe-MOXs-catalyzed luminol CL system, suggesting that the CL emission of luminol might originate from the intrinsic oxidase-like catalytic activity of Fe-MOXs on the decomposition of dissolved oxygen. Additionally, the potential practical application of the resulting luminol-Fe-MOXs system was evaluated by the quantitative analysis of dopamine. Good linearity over the range from 0.05 to 0.6 µM was obtained with the limit of detection (LOD, 3σ) of 20.4 nM and acceptable recoveries ranging from 98.6 to 105.4% in human urine. These results may open up the promising application of novel metal-organic gels as highly effective catalysts in the field of chemiluminescence.

Co-metal-organic-frameworks with pure uniform crystal morphology prepared via Co2+ exchange-mediated transformation from Zn-metallogels for luminol catalysed chemiluminescence.

Cation exchange-mediated transformation from Zn-metallogels (MOGs), which was a mild facile strategy relative to the demanding hydrothermal method, was employed to develop Co2+ metal-organic frameworks (Co-MOFs) at room temperature. The obtained Co-MOFs was of uniform octahedral morphology and possessed high activity to catalyze luminol chemiluminescence without extra oxidants. By adding cysteine, the CL emission of luminol-Co-MOFs system was further enhanced. Based on this phenomenon, Co-MOFs was utilized to build a practical sensing platform for cysteine determination. Under the optimized conditions, the relative CL intensity (ΔI) was proportional to the concentration of cysteine in the range of 2-10µM, and the detection limit was 0.49µM (3S/N). Moreover, the established method was applied to the determination of cysteine in commercially available pharmaceutical injections.